Abstract
Of all the gynecologic malignancies, ovarian cancer has been the most extensively studied in hematopoietic cell-supported high-dose chemotherapy trials. This strategy has not been tested in patients with cervical, endometrial, or vulvar carcinoma, other than their rare inclusion in phase I trials. Therefore, for the purposes of this review, we focus on the high-dose chemotherapy studies of ovarian cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
